MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES

Clinical trials for MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES explained in plain language.

Never miss a new study

Get alerted when new MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES trials appear

Sign up with your email to follow new studies for MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug could help boys with duchenne walk and move longer

Disease control Recruiting now

This study tests a new medicine called DYNE-251 in boys aged 4 to 18 with Duchenne muscular dystrophy (DMD) who can still walk. The goal is to see if it helps them move better and slows muscle damage. Participants will receive either the drug or a placebo every 4 weeks for about …

Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES

Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control

Last updated Jun 09, 2026 12:07 UTC

MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES

Get alerted when new MUSCULAR DYSTROPHY, DUCHENNE AND BECKER TYPES trials appear

New drug could help boys with duchenne walk and move longer